BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
35.81
+1.45 (4.22%)
At close: Sep 30, 2026
| Market Cap | 15.59B -37.9% |
| Revenue (ttm) | 1.36B +17.4% |
| Net Income | 96.27M -3.7% |
| EPS | 0.23 -2.0% |
| Shares Out | 435.23M |
| PE Ratio | 154.42 |
| Forward PE | n/a |
| Dividend | 0.02 (0.04%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 12,909,438 |
| Open | 34.37 |
| Previous Close | 34.36 |
| Day's Range | 34.23 - 36.55 |
| 52-Week Range | 28.74 - 72.88 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |